A*STAR Genome Institute of Singapore (A*STAR GIS)
Bringing a major culprit in advanced gastric cancer to light
5 Jul 2022Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.
Figuring out RNA one fold at a time
15 Jun 2022Understanding the mechanisms behind RNA structure and folding could pave the way for more effective medical treatments, say Yue Wan and Ashley Aw.
Nucleic acid therapeutics: Riding the wave of mRNA
7 Jun 2022Ushering in an era of targeted precision medicine, scientists across A*STAR are propelling the research, commercialisation and implementation of RNA-based therapeutics.
Speaking the same immune language
12 May 2022The first open-access database of mononuclear phagocytes, created by A*STAR researchers, provides insight into the biology of these immune cells and their roles in fighting disease.
Delivering therapies to the heart’s core
7 Apr 2022Nuevocor, an A*STAR spin-off company, is designing novel therapies to target the genetic causes of heart diseases, bringing basic research to clinical impact.
A*STAR scholars then and now
10 Mar 2022Supported by A*STAR in the early days of their budding careers, scholars recount the experiences that opened the doors to bigger successes from academia to public service.
Unmasking key players in the SARS-CoV-2 infection process
23 Feb 2022SARS-CoV-2 genome structures and their interactions with human RNA are shown to be important in virus survival and pathogenicity.
Shaping a legacy of scientific excellence
15 Dec 2021Honored with the President’s Science and Technology Awards, A*STAR researchers are shaping Singapore’s scientific landscape. Here, we spotlight three researchers who have pushed the boundaries in foundational biomedical research, translational engineering efforts and cross-cutting collaborations.
Three decades of driving dedicated research
7 Dec 2021Through the years, A*STAR has always stood at the forefront of science and technology and innovation. Here’s how A*STAR came to be and what it has in store in the upcoming decades.
Mapping modified RNA with xPore
7 Dec 2021A new computational method called xPore identifies and estimates the number of specific RNA modifications in biological samples.
A closer look into the genetics of blindness
5 Dec 2021Using whole-exome sequencing, scientists have identified a gene likely linked to a common eye disorder that can lead to blindness in the elderly.
COVID-19’s far-reaching effects from lung to liver
30 Nov 2021Using single-cell sequencing technology, A*STAR scientists have identified a rare population of liver cells susceptible to damage from SARS-CoV-2 infections.